Lecture 32 - Drugs Acting Through Receptors 2 Flashcards

1
Q

What is potency?

A

Affinity

Efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Do drugs with different potencies reach the same maximum?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the difference between a weak agonist and a full agonist?

A

Different efficacies:
Weak: little response in the cell
Full: full response in the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is potency?

A

The amount of drug required to elicit a certain response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Draw a dose-response curve of two drugs with different potencies

A

:)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Will a weak agonist ever reach the maximum?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Will partial agonists ever reach the maximum?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is intrinsic efficacy?

A

This is the ability of the ligand to elicit a response in the cell

It is a property of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is coupling in pharmacology?

A

Transduction

This is the relationship between the binding of the ligand to the receptor and the transduction pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The greater the coupling, …

A

the greater the intrinsic efficacy of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Draw a stimulus-response curve for two drugs of different coupling efficiency

A

Lecture 31

Slide 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Draw a concentration-response curve:

  • one drug
  • different numbers of receptors
A

Lecture 31

Slide 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the ‘gold-standard’ B-adrenoceptor agonist?

A

Isoprenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the features of isoprenaline?

A

High intrinsic efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Compare isoprenaline with prenalterol

A

Isoprenaline: high intrinsic efficacy
Prenalterol: modest instrinsic efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe an instance of tissue-dependency of the agonist

A

Prenalterol

Has much less of a response in the gut than in the atria due to the receptor density

17
Q

Describe an instance of disease-dependence of an agonist’s activity

A

Prenalterol

TIssue has been desensitised to Prenalterol.
Has much less of a response in failing heart than in healthy heart, due to receptor number

Isoprenaline is also less potent in the failing heart

18
Q

What are the drug-dependent factors of potency?

A

I/ Affinity

II/ Efficacy

19
Q

What are the tissue-dependent factors of potency?

A

I/ Number of receptors

II/ Coupling

20
Q

What are the different types of antagonism?

A

I/ Chemical

II/ Functional
Mechanical

21
Q

Describe an example of chemical antagonism

A

Protamine binds to heparin, neutralising it

22
Q

What type of molecule is protamine?

A

A polycation

23
Q

What is competitive antagonism?

A

This is when a molecule binds to the active site of a receptor, preventing a response

24
Q

What is surmountable antagonism?

A

The antagonism can be overcome by adding more of the agonist

Concontration dependent antagonism

25
Q

Describe the two sites that the agonist and antagonist act on in competitive antagonism

A

They act on the same site

26
Q

Draw a concentration-response graph of a drug at a certain concentration when there is an antagonist present, and when there is no antagonist

A

Slide 28

27
Q

Draw a dose-response curve of a drug when there is and isn’t an antagonist present

A

Slide 29

28
Q

Is the maximum still reached in competitive antagonism?

A

Yes - if the concentration of the agonist is high enough

29
Q

What is happening in non-competitive inhibition?

A

The antagonist is binding to an allosteric site, leading to a change in the shape of the active site

30
Q

What is the reason for the difference between partial and full agonists?

A

Different functional groups